Chronic Disease Management Market Research: When Singapore Patients Don't Do What They're Told
Assembled is a market research agency in Singapore with 600+ projects completed across Southeast Asia since 2016, a 100,000-member proprietary panel, and publications in MRS Research Live and ESOMAR Research World. This chronic disease management adherence in Singapore analysis draws on patterns from healthcare research projects moderated by founder Felicia Hu, who scopes, moderates, analyses, and presents every project herself. In Singapore’s high-context culture, a participant who says “can consider” is saying no. Felicia, a bilingual moderator in English and Mandarin with fluency in Hokkien, Cantonese, and Singlish, was recently quoted in the South China Morning Post on Singapore consumer healthcare decisions.
The HPB National Population Health Survey shows that approximately one in three Singapore residents aged 18-74 has at least one chronic condition (diabetes, hypertension, high cholesterol, or obesity). That's a significant prevalence. Yet research into why patients don't follow treatment often stops at the surface. "They forget." "They don't understand." "They're not motivated." These explanations are clean and simple. They're also wrong, I think. Or at least, they're incomplete.
The real story is more textured. It involves how patients feel, what they believe their bodies are telling them, how Singapore's healthcare system makes them feel, whether the condition carries social shame, and whether they trust their doctor more than they trust themselves. It appears that these factors predict adherence far better than education level or access to medication ever will.
The Feeling Fine Problem
Start here: a patient prescribed medication for hypertension or high cholesterol often feels no different taking pills versus not taking them. The medication is working, the doctor says. Your blood pressure is lower. Your cholesterol is down. But you feel exactly the same as yesterday. No symptom relief. No energy boost. No visible change. The medication is preventing something bad from happening in the future (a stroke, a heart attack), but that prevention is invisible. You might be thinking this is obvious, right? People should take preventive medication because they intellectually understand prevention. But here's what the research shows: knowing something intellectually and doing it consistently are fundamentally different challenges.
Patients often report: "I only take my medication when I feel unwell." But the medication for these chronic conditions is meant to prevent feeling unwell. The logic creates a trap. No symptoms means the medication isn't working, so why take it? This isn't irrationality. It's a rational response to invisible benefit.
The Medisave Anxiety Layer
Singapore's Medisave system creates unexpected behavioral effects that most adherence research doesn't capture. Patients see their Medisave balance declining with each prescription refill and develop genuine anxiety about funds being "wasted" on preventive medication. They worry about depleting savings for "real" illness, meaning acute, symptomatic illness. The MOH Chronic Disease Management Programme (CDMP) helps with costs, but patient perception often doesn't reflect the actual financial burden being subsidized. Patients see the Medisave deduction and interpret it as cost, regardless of what subsidy arrangements exist behind it.
This creates a secondary decision-making layer that purely clinical research misses. The patient is balancing perceived financial risk against perceived health benefit. When the health benefit is invisible and the financial cost appears visible, the decision can swing toward non-adherence.
Polyclinic Fatigue and Belonging
Long waits, brief consultations, and different doctors each visit erodes patient engagement. After the fifth visit where you spend 45 minutes waiting to see a doctor for a 7-minute consultation with someone you've never met before, something shifts. You feel like "just a number." Over time, this leads to appointment skipping. The condition goes unmonitored until a crisis forces intervention. CNA has covered Singapore's polyclinic capacity pressures extensively, and the experience gap is real.
It appears that healthcare experience quality directly shapes adherence behaviors. A patient who feels respected and heard by their doctor is more likely to adhere. A patient who feels rushed and anonymous is more likely to eventually stop engaging. SingHealth's chronic disease programmes have invested in continuity of care models precisely because the research supports this link. And the Agency for Integrated Care has built a whole framework around the idea that community-level care coordination improves chronic disease outcomes — which only makes sense if the experience layer actually matters.
The Stigma Layer
Some conditions carry specific stigma in Singapore culture. Diabetes is associated with dietary indiscipline, creating shame. Patients hide the condition from family, avoid medication in social settings, and resist insulin because it signals "serious" disease. Mental health comorbidities, which often accompany chronic physical illness, go entirely untreated due to stigma concerns. A patient managing diabetes and depression but only seeking treatment for one is accurately reflecting the stigma burden attached to acknowledging the second.
How Patients Actually Segment
| Patient Segment | Prevalence | Adherence Pattern | Core Motivation |
|---|---|---|---|
| Disciplined Compliers | 15-20% | Follow advice consistently. Integrated medication into daily routine. | Often experienced a health scare that motivated sustained change. |
| Optimistic Adjusters | 25-30% | Believe they can manage through partial compliance. Take medication "most days." Skip when feeling well. | "I know my body better than guidelines do." Self-assessment overrides medical guidance. |
| Reluctant Participants | 20-25% | Don't want to be identified as "sick." Comply minimally to satisfy family or avoid doctor conflict. | Would stop if they thought no one would notice. |
| Overwhelmed Non-Copers | 15-20% | Multiple conditions, complex regimens, limited support. Miss appointments because scheduling is complicated. Miss doses because too many pills. | Deteriorates through chaos rather than choice. |
| Active Deniers | 10-15% | Reject diagnosis or treatment. Pursue TCM, diet, supplements instead. | May return only after crisis demonstrates Western medicine's necessity. |
This segmentation reveals something crucial: non-adherence isn't one problem. It's five different problems, each requiring different interventions. The forgetfulness of the Overwhelmed Non-Coper won't be solved by the same strategy that addresses the belief system conflict of the Active Denier.
What Actually Stops People from Taking Medication
| Adherence Barrier | Severity | Example |
|---|---|---|
| Lack of perceived benefit | Very High | "I feel the same whether I take it or not" |
| Side effect concerns | High | "The medication makes me feel worse than the disease" |
| Regimen complexity | High | "I can't remember what to take when" |
| Cost concerns | Moderate | "I skip doses to make medication last longer" |
| Lifestyle interference | Moderate | "Taking medication during lunch meeting is awkward" |
| Belief system conflict | Moderate | "I prefer natural remedies" |
Here's what I find interesting: the barriers that research traditionally emphasizes (cost, access, knowledge) aren't the top barriers for most patients. The top barriers are psychological and emotional. This reframing changes everything about how you design interventions.
What Interventions Actually Work
| Barrier | Intervention | Effectiveness |
|---|---|---|
| Lack of perceived benefit | Tangible feedback (home BP monitors, glucose tracking apps) | Moderate — Makes invisible benefit visible |
| Side effect concerns | Alternative formulations, side effect management, expectation setting | Variable — Depends on actual vs. perceived side effects |
| Regimen complexity | Reminder apps, pill organizers, routine integration (take with breakfast) | Good if purely logistical; less effective if psychological resistance exists |
| Cost concerns | Generic alternatives, subsidy navigation help | Good — Addresses real constraint |
| Lifestyle interference | Once-daily formulations, discrete delivery methods | Good — Reduces friction |
| Belief system conflict | Integration messaging (Western + TCM), trusted community voices | Difficult — Requires deep belief change |
The interventions that work are the ones that address the actual barrier, not the assumed barrier. A patient who doesn't take medication because it conflicts with their belief system won't be helped by a reminder app. A patient who forgets genuinely doesn't need counseling about belief systems.
What Research Methods Miss
Most adherence research is built on assumptions that get verified in clean ways. Surveys ask "Do you take your medication?" and patients report high adherence rates. Focus groups ask "What would help you take your medication?" and patients list rational solutions. Pharmacy refill data shows inconsistency but doesn't explain why.
None of these approaches captures the emotional and social truth. This is a moment to say: the research that gets the most honest answers isn't the research that asks the most direct questions. You might be thinking that's counterintuitive, but qualitative research shows this repeatedly. Deeper questions about what patients believe about their bodies, how they make decisions, what they're worried about, and what they value generates adherence insights that direct questions never reveal.
What research gets wrong about adherence:
First, it assumes adherence is rational. Knowledge isn't the barrier. Behavior change research shows that information rarely drives action on its own. People know they should exercise. They know they should eat better. Information abundance doesn't equal behavior change.
Second, it treats all non-adherence identically. The forgetter needs reminders. The denier needs something else entirely. The Medisave-anxious patient needs financial reassurance. Treating these as one problem produces interventions that work for nobody.
Third, it ignores the healthcare experience itself. A patient who feels respected and heard is more likely to adhere. A patient who feels rushed and unheard is more likely to eventually disconnect.
Observations in this post draw on patterns from Assembled’s healthcare research projects in Singapore, including in-depth interviews, focus group discussions, and related methodologies. Secondary data from MOH health statistics and HPB National Population Health Survey. For research enquiries, contact felicia@assembled.sg., our research guide
For Healthcare Leaders and Researchers
If you work in healthcare and you're trying to understand why patients don't follow treatment, the research you need isn't the research you might think. You need to understand patients as whole people with competing values, beliefs, fears, and constraints. You need to see them in context, not in a focus group facility.
You also need to listen to what they don't say as much as what they do. The patient who says they'll take medication but doesn't is telling you something valuable. The patient who asks about side effects is telling you about fear. The patient who asks about Medisave deductibility is telling you about financial anxiety. These signals are research data.
Consider exploring the role of caregivers in chronic disease management, since family often shapes medication decisions. You might also benefit from understanding the broader patient journey in Singapore healthcare. And if your chronic disease population has mental health comorbidities, understanding what patients won't tell you about mental health becomes essential.
Understanding why your patients stop doing what they agreed to do
Adherence research requires behavioural probing, not satisfaction surveys. We design studies that capture the gap between what patients tell their doctor and what they actually do at home.
Request a quote →Why This Matters for Singapore Healthcare
Singapore's healthcare system is efficient, accessible, and well-subsidized. Yet adherence remains a critical gap between what's clinically possible and what's actually achieved. Understanding why patients don't do what they're told isn't about blame or judgment. It's about designing healthcare that works with human behavior, not against it.
The stakes are significant. Poor adherence to hypertension medication increases stroke risk. Poor adherence to diabetes management increases complications. These aren't abstract clinical outcomes. They're lives affected, healthcare costs escalated, and preventable suffering. Research that reveals the real barriers enables better interventions, better patient education, better healthcare design.
At least, that's my reading of the evidence. But I'm still working through what integration of all these barriers means for your specific healthcare context.
Frequently Asked Questions
Why do Singapore patients with chronic diseases not take their medication consistently?
Research reveals multiple barriers operating simultaneously. Patients often lack visible benefit perception (they feel the same on or off medication), experience Medisave depletion anxiety, develop polyclinic fatigue from healthcare system experience, or face stigma associated with their condition. Non-adherence isn't a single behavioral failure but rather a complex negotiation between competing values and constraints. Different patients have different primary barriers, requiring customized understanding rather than one-size-fits-all solutions.
What is the difference between non-adherence and non-compliance in healthcare research?
Non-compliance traditionally referred to a patient's failure to follow medical instructions, framing it as a patient problem. Non-adherence is a more neutral term that acknowledges the patient's agency in decision-making and the complex factors influencing those decisions. Modern research uses "adherence" to signal that we're examining the full context of patient choices, not just judging whether instructions were followed. This semantic shift reflects deeper understanding that medication-taking is a complex behavioral choice, not a simple compliance issue.
How do we research medication adherence without patients telling us what we want to hear?
Patients often report high adherence in direct surveys because they sense social desirability pressure to appear responsible. More reliable approaches include behavioral tracking (pharmacy refill data, app usage), indirect questioning about decision-making processes, ethnographic observation of medication routines, and in-depth interviews that build enough trust to enable honest discussion. Pharmacy refill patterns combined with qualitative exploration of barriers reveals discrepancies between what patients say and what they do, surfacing the actual barriers to adherence.
What research methods work best for understanding chronic disease patient behavior?
Mixed methods approaches combining quantitative data (pharmacy records, clinical outcomes) with qualitative insight (in-depth interviews, observational research) produce the most complete understanding. Qualitative research specifically designed to explore emotional and social factors, conducted with sufficient depth to build trust, reveals barriers that surveys and focus groups miss. Ethnographic approaches that observe patients in their actual medication routines (at home, at work) often reveal the contextual barriers that clinical research settings don't capture.
How does Medisave affect medication adherence behavior in Singapore?
Medisave creates psychological effects beyond its intended financial protection. When patients see their Medisave balance declining with each prescription refill, they develop anxiety about depleting funds for "real" acute illness. This generates a competing cost-benefit calculation where preventive medication is perceived as consuming funds needed for more urgent health needs. Even though the MOH CDMP subsidizes many chronic disease costs, patient perception of the Medisave deduction shapes behavior. Understanding patient financial psychology, not just financial reality, is essential for addressing Medisave-related adherence barriers.
